Tina Cascone

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0003-3008-5407

发表论文 458 篇 · 总被引 13569 次 · h-index 55

代表论文

• The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets (2026 · Nature Cancer · 被引 1)
• Biomarkers of nivolumab benefit in resectable non-small cell lung cancer (2026 · Nature)
• Data from Improving Anti–CTLA-4 Therapies through Peptide Masking and Fragment Crystallizable Non-fucosylation: Preclinical Characterization of Three Novel Antibodies (2026)
• Supplementary Data from Improving Anti–CTLA-4 Therapies through Peptide Masking and Fragment Crystallizable Non-fucosylation: Preclinical Characterization of Three Novel Antibodies (2026)
• Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT (2026 · Lung Cancer)
• Unbiased avidity-based isolation of antigen-specific T cells (2026 · Journal for ImmunoTherapy of Cancer)